RA Capital Management, L.P. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 9,095,589 9.990% | 898,256 (+10.96%) | Filing |
| 2024-02-14 5:01 pm Sale | 2024-02-14 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 8,197,333 9.900% | -1,136,000 (-12.17%) | Filing |
| 2023-08-01 4:30 pm Purchase | 2023-06-08 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 9,333,333 11.300% | 5,000,000 (+115.38%) | Filing |
| 2022-12-02 4:30 pm Purchase | 2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 4,333,333 5.290% | 4,333,333 (New Position) | Filing |